Skip to main content
Log in

EC-MPS preferred choice in kidney transplantation

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Martinez-Mier G, et al. The Cost of Gastrointestinal Adverse Events and the Impact of Dose-Reductions/Discontinuations on Acute Rejection in Kidney Transplant Patients of Mycophenolate Mofetil-Related Compared to Enteric-Coated Mycophenolate Sodium: A Pharmacoeconomic Study. Transplantation Proceedings 48: 588-95, No. 2, Mar 2016

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

EC-MPS preferred choice in kidney transplantation. PharmacoEcon Outcomes News 752, 9 (2016). https://doi.org/10.1007/s40274-016-3003-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3003-7

Navigation